Same Cancer Drugs, New Applications

At the American Society of Clinical Oncology gathering, the talk isn't of the brand new, but of expanded uses for current treatments

The word of the week at the world's largest cancer meeting is "incremental." Some of the most notable data presented during the first two days of the annual American Society of Clinical Oncology (ASCO) meeting, June 1-5 in Chicago, was on new uses for existing drugs, rather than promising medicines still in the pipeline.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.